Emerald Advisers’s 89bio ETNB Stock Holding History

Emerald Advisers’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-535,147	Closed	-$7.87M	–	254
2025 Q3	$7.87M	Sell	535,147 -1,309,223	-71%	-$13.3M	0.25%	105
2025 Q2	$18.1M	Buy	1,844,370 +293,699	+19%	+$2.43M	0.66%	58
2025 Q1	$11.3M	Buy	+1,550,671	New	+$13.6M	0.51%	79

Other funds holding ETNB

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Emerald Advisers's ETNB Position: Q4 2025 in Review

Emerald Advisers sold out of 89bio (ETNB) in Q4 2025, closing a stake of 535,147 shares — an estimated $7.87M sold.

Emerald Advisers first reported a position in ETNB in Q1 2025 and held it in 3 quarters. The position peaked at $18.1M in Q2 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

Emerald Advisers reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
Emerald Advisers sold 535,147 89bio shares in Q4 2025, an estimated $7.87M.
Emerald Advisers first reported a position in 89bio in Q1 2025 and held it in 3 quarters.
Emerald Advisers's 89bio position peaked at $18.1M in Q2 2025.
2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Emerald Advisers's 13F filing for Q4 2025, filed 9 Feb 2026.